4015 logo

Jamjoom Pharmaceuticals Factory Company Stock Price

SASE:4015 Community·ر.س11.0b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 17 Fair Values set on narratives written by author
Create a narrative

4015 Share Price Performance

ر.س156.60
-8.40 (-5.09%)
12.2% undervalued intrinsic discount
ر.س178.41
Fair Value
ر.س156.60
-8.40 (-5.09%)
12.1% undervalued intrinsic discount
ر.س178.20
Fair Value
Price ر.س156.60
AnalystConsensusTarget ر.س178.20

4015 Community Narratives

AnalystConsensusTarget·Updated
Fair Value ر.س178.41 12.2% undervalued intrinsic discount

Rising MENA Demand And Vision 2030 Investments Will Redefine Markets

0users have liked this narrative
0users have commented on this narrative
9users have followed this narrative

Recent 4015 News & Updates

Investor Optimism Abounds Jamjoom Pharmaceuticals Factory Company (TADAWUL:4015) But Growth Is Lacking

Sep 05
Investor Optimism Abounds Jamjoom Pharmaceuticals Factory Company (TADAWUL:4015) But Growth Is Lacking
User avatar

Facilities In Jeddah Egypt And Algeria Will Expand MENA Markets

Expanding production capacity, strategic market entries, and international partnerships are driving operational efficiency, revenue growth, and geographic diversification.

Investor Optimism Abounds Jamjoom Pharmaceuticals Factory Company (TADAWUL:4015) But Growth Is Lacking

Apr 14
Investor Optimism Abounds Jamjoom Pharmaceuticals Factory Company (TADAWUL:4015) But Growth Is Lacking

Earnings Miss: Jamjoom Pharmaceuticals Factory Company Missed EPS By 5.1% And Analysts Are Revising Their Forecasts

Mar 08
Earnings Miss: Jamjoom Pharmaceuticals Factory Company Missed EPS By 5.1% And Analysts Are Revising Their Forecasts

Jamjoom Pharmaceuticals Factory Company Key Details

ر.س1.4b

Revenue

ر.س546.8m

Cost of Revenue

ر.س894.2m

Gross Profit

ر.س458.6m

Other Expenses

ر.س435.7m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
6.22
Gross Margin
62.05%
Net Profit Margin
30.23%
Debt/Equity Ratio
0%

Jamjoom Pharmaceuticals Factory Company Competitors

 
 
 
 
 
 
 
 
 
 
 
 
View more competitors

Snowflake Analysis

Outstanding track record with flawless balance sheet.

0 Risks
4 Rewards
View Full Analysis

About 4015

Founded
1994
Employees
n/a
CEO
Tarek Youssef Hosni
WebsiteView website
www.jamjoompharma.com

Jamjoom Pharmaceuticals Factory Company manufactures and markets pharmaceutical products in the Kingdom of Saudi Arabia and internationally. The company offers products human medicines, nutraceuticals, antibiotics, general analgesics, medicines for treatment of cough, allergy, asthma, heart diseases, blood pressure, diarrhea, vomiting, ulcer, and acidity, as well as various skin infections, cancer diseases, eye drops and ointments, and cosmeceuticals. Jamjoom Pharmaceuticals Factory Company was founded in 1994 and is based in Jeddah, the Kingdom of Saudi Arabia.

Market Insight

Header cover image

✨Rare Earths: Tiny Market, Outsized Influence

Richard Bowman avatarRichard Bowman
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Last Week
⚡ Utilities: Defensive Dividends Meet the AI Power Surge

⚡ Utilities: Defensive Dividends Meet the AI Power Surge

Saudi Arabian Market Performance

  • 7 Days: 1.7%
  • 3 Months: 0.8%
  • 1 Year: -7.9%
  • Year to Date: -9.5%
Over the last 7 days, the market has risen 1.7%, driven by gains in every sector, especially the Energy sector. Longer term the market is actually down 7.9% over the past year. As for the next few years, earnings are expected to grow by 8.2% per annum. Market details ›